CA2181581A1 - Derives de benzylamine contenant des groupes nitroxy et leur utilisation pour traiter les maladies cardio-vasculaires et l'hypertension intra-oculaire - Google Patents
Derives de benzylamine contenant des groupes nitroxy et leur utilisation pour traiter les maladies cardio-vasculaires et l'hypertension intra-oculaireInfo
- Publication number
- CA2181581A1 CA2181581A1 CA002181581A CA2181581A CA2181581A1 CA 2181581 A1 CA2181581 A1 CA 2181581A1 CA 002181581 A CA002181581 A CA 002181581A CA 2181581 A CA2181581 A CA 2181581A CA 2181581 A1 CA2181581 A1 CA 2181581A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- alkyl
- phenyl
- radical
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Des composés ont la formule (I), dans laquelle R1 désigne alcylène C¿1-15?, cycloalkylène C¿5-7? ou di-1-4C-alcylène-5-7C-cycloalcane; R1 désigne hydrogène, alcoyle C¿1-7? ou cycloalcoyle C¿3-8? et R2 désigne hydrogène, alcoyle C¿1-7?, cycloalcoyle C¿3-8? ou A2-Y. Ensemble, R1 et R2, avec l'atome d'azote auquel ils sont tous les deux liés, désignent un hétérocycle pentagonal, hexagonal ou heptagonal substitué ou non sélectionné dans le groupe constitué par la pyrrolidine, la pipéridine, la pipérazine, la morpholine et l'homopipérazine. A2 désigne alcylène C¿1-15?, cycloalcylène C¿5-7? ou di-1-4C-alcylène-5-7C-cycloalcane; Y désigne R3, NH¿2?, NH-R4 ou S-R5. Un résidu pyrrolidine substitué est substitué par un ou deux substituants identiques ou différents sélectionnés dans le groupe constitué par alcoyle C¿1-4?, alcoxy C¿1-4? et hydroxyle. Un résidu pipéridine substitué est substitué par un ou deux substituants identiques ou différents sélectionnés dans le groupe constitué d'alcoyle C¿1-4?, alcoxy C¿1-4? et hydroxyle. Un résidu pipérazine substitué peut être substitué en 2e, 3e, 5e ou 6e position par un résidu alcoyle C¿1-4? et est substitué en 4e position par un substituant sélectionné dans le groupe constitué d'alcoyle C¿1-4?, alcoxycarbonyle C¿1-4?, alcoylcarbonyle C¿1-4?, phényle substitué par R6, R7 et R8, phényl-1-4C-alcoyle substitué dans le résidu phényle par R7 et R8, benzoyle, picolinoyle, nicotinoyle, isonicotinoyle substitués dans le résidu phényle par R6, R7 et R8, benzhydryle substitué le cas échéant par halogène ou alcoyle C¿1-4? et le résidu R4. Un résidu morpholine substitué est substitué par un ou deux résidus alcoyle C¿1-4? identiques ou différents. Un résidu homopipérazine substitué est substitué en 4e position par un substituant sélectionné dans le groupe constitué d'alcoyle C¿1-4?, alcoxycarbonyle C¿1-4?, alcoylcarbonyle C¿1-4?, phényle substitué par R6, R7 et R8, phényl-1-4C-alcoyle substitué dans le résidu phényle par R6, R7 et R8 et benzoyle substitué dans le résidu phényle par R6, R7 et R8. Ces composés sont utiles pour traiter les maladies cardio-vasculaires ainsi que l'hypertension intra-oculaire.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH15794 | 1994-01-19 | ||
CH157/94-2 | 1994-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2181581A1 true CA2181581A1 (fr) | 1995-07-20 |
Family
ID=4180558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002181581A Abandoned CA2181581A1 (fr) | 1994-01-19 | 1995-01-18 | Derives de benzylamine contenant des groupes nitroxy et leur utilisation pour traiter les maladies cardio-vasculaires et l'hypertension intra-oculaire |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0740649A1 (fr) |
JP (1) | JPH09507672A (fr) |
KR (1) | KR970700646A (fr) |
CN (1) | CN1143950A (fr) |
AU (1) | AU679834B2 (fr) |
BR (1) | BR9506549A (fr) |
CA (1) | CA2181581A1 (fr) |
WO (1) | WO1995019952A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8067464B2 (en) | 2004-10-04 | 2011-11-29 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
CN101889017B (zh) | 2007-10-05 | 2013-11-27 | 奥克塞拉有限公司 | 用于治疗疾病的烷氧基化合物 |
GB2455176A (en) | 2007-11-01 | 2009-06-03 | Acucela Inc | Amine derivatives useful for treating ophthalmic diseases and disorders |
EP2448569B1 (fr) | 2009-07-02 | 2021-10-27 | Acucela, Inc. | Pharmacologie de modulateurs du cycle visuel |
AU2010328230B2 (en) * | 2009-12-07 | 2016-06-02 | Cardioxyl Pharmaceuticals, Inc. | Bis-acylated hydroxylamine derivatives |
EP2804605A4 (fr) | 2012-01-20 | 2015-07-08 | Acucela Inc | Composés hétérocycliques substitués pour le traitement d'une maladie |
US9446015B2 (en) * | 2012-10-23 | 2016-09-20 | Nicox Science Ireland | Quinone based nitric oxide donating compounds for ophthalmic use |
HUE046722T2 (hu) * | 2013-01-18 | 2020-03-30 | Cardioxyl Pharmaceuticals Inc | Javított terápiás indexû nitroxil donorok |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56113748A (en) * | 1980-02-13 | 1981-09-07 | Kowa Co | Aminoethanol derivative and its preparation |
NL8802276A (nl) * | 1988-09-15 | 1990-04-02 | Cedona Pharm Bv | Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat. |
NL9001955A (nl) * | 1990-09-05 | 1992-04-01 | Cedona Pharm Bv | Nieuwe thiazolidinederivaten. |
-
1995
- 1995-01-18 CA CA002181581A patent/CA2181581A1/fr not_active Abandoned
- 1995-01-18 BR BR9506549A patent/BR9506549A/pt not_active Application Discontinuation
- 1995-01-18 AU AU15350/95A patent/AU679834B2/en not_active Expired - Fee Related
- 1995-01-18 JP JP7519335A patent/JPH09507672A/ja active Pending
- 1995-01-18 CN CN95192048A patent/CN1143950A/zh active Pending
- 1995-01-18 KR KR1019960703871A patent/KR970700646A/ko not_active Application Discontinuation
- 1995-01-18 WO PCT/EP1995/000167 patent/WO1995019952A1/fr not_active Application Discontinuation
- 1995-01-18 EP EP95906963A patent/EP0740649A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU679834B2 (en) | 1997-07-10 |
JPH09507672A (ja) | 1997-08-05 |
EP0740649A1 (fr) | 1996-11-06 |
CN1143950A (zh) | 1997-02-26 |
BR9506549A (pt) | 1997-10-14 |
KR970700646A (ko) | 1997-02-12 |
AU1535095A (en) | 1995-08-08 |
MX9602847A (es) | 1997-12-31 |
WO1995019952A1 (fr) | 1995-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3900481A (en) | Derivatives of pyrrolidine and piperidine | |
US5859246A (en) | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands | |
ZA200006136B (en) | Nitrate salts of antihypersensive medicines. | |
WO2001089528A1 (fr) | Derives thio-uree de dihydropyridines possedant une activite d'antagonistes de npy | |
TW442456B (en) | Diaryl antimicrobial agents | |
HU191643B (en) | Process for preparing new n-phenyl-n'-cycloalkyl-alkanoyl-piperazine derivatives | |
GB2158065A (en) | Dihydropyridines | |
CA2181581A1 (fr) | Derives de benzylamine contenant des groupes nitroxy et leur utilisation pour traiter les maladies cardio-vasculaires et l'hypertension intra-oculaire | |
US5852019A (en) | Pyrimidinylpyrazole derivatives | |
IE912492A1 (en) | 1,4-disubstituted piperazines | |
HU185975B (en) | Process forproducing new, benzoaxazolinone derivatives substituted with an aminoalkohol- or aminoketone chain at the 6 position and pharmaceutically acceptable salts thereof | |
CS229924B2 (en) | Production method of new phenylalkylamine | |
AU731638B2 (en) | Novel terephthalamide derivatives | |
US5095022A (en) | Piperidine derivatives and pharmaceutical compositions comprising the same | |
IE911774A1 (en) | Pyridinylpiperazine derivatives | |
US9273027B2 (en) | Arylpiperazine opioid receptor antagonists | |
US4556656A (en) | 2-Benzoxepins | |
IE45051B1 (en) | 2-substituted-4-amino-6,7-dimethoxy-quinazolines | |
EP0799210A1 (fr) | Derives de la piperazine-2,5-dione employes comme modulateurs de la resistance multiple aux anticancereux | |
JP3041834B2 (ja) | N―アミノアルキル―2―アントラキノンカルボキサミド;ドーパミンレセプターサブタイプに特異的な新しい配位子 | |
JPS6069089A (ja) | ジヒドロピリジン−5−ホスホネ−ト誘導体およびその製造法 | |
US4029790A (en) | 1-Benzoyl-2 or 4 [2-(4-phenyl-piperazino)-ethyl]-piperidines | |
US4220603A (en) | Pharmaceutically active (omega-aminoalkoxy)bibenzyls | |
EP0266549B1 (fr) | Cinnamylamines, leur procédé de préparation et compositions pharmaceutiques les contenant | |
KR100373957B1 (ko) | 신규한아민유도체,그의제조방법및항부정맥제로서의용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |